Observation study for availability of phone support service for management of Capecitabine in patients with Colorectal Cancer(XTRA study)

Observation study for availability of phone support service for management of Capecitabine in patients with Colorectal Cancer(XTRA study) - Observation study for availability of phone support service for management of Capecitabine in patients with Colorectal Cancer(XTRA study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004429

Enrollment

Registered

2010-10-25

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Capecitabine in treatment 2.Written informed consents 3.Age:>20 years 4.ECOG-PS:0-2

Exclusion criteria

Exclusion criteria: 1.Uncontrolled Diarrhea 2.Other conditions not suitable for this study

Design outcomes

Primary

Measure	Time frame
Safety(grade3 of Hand-Foot Syndrome)	—

Secondary

Measure	Time frame
Premature withdrawal rate treatment interruption rates Time to recovery of HFS after interruption Mean cumulative dose Mean treatment duration Compliance duration of phone call	—

Countries

Japan

Outcome results